"Molecularly targeted therapies are effective alternatives to conventional treatments ... is a clinical-stage biotechnology company developing a diverse portfolio of therapeutic candidates in ...
The Company’s common stock commenced trading under the trading symbol “GRCE” on Nasdaq effective October 28, 2024 ... and more convenient drug delivery. Grace Therapeutic’s lead clinical assets have ...